US-based biotechnology company Inceptor Bio has dosed the first subject in the investigator-initiated trial of its lead ...

Inceptor Bio, a clinical-stage biotechnology company pioneering next-generation cell therapies, today announced that the first patient has been dosed in the clinical trial of IB-T101, the company's ...